Late consequences of the Fontan operation

Circulation. 2014 Oct 21;130(17):1525-8. doi: 10.1161/CIRCULATIONAHA.114.005341.

Authors

Jack Rychik¹, David J Goldberg²

Affiliations

¹ From the Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, PA (J.R., D.J.G.); Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA (J.R., D.J.G.). [email protected].
² From the Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, PA (J.R., D.J.G.); Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA (J.R., D.J.G.).

PMID: 25332280
DOI: 10.1161/CIRCULATIONAHA.114.005341

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't
Review

MeSH terms

Adolescent
Budesonide / therapeutic use
Fontan Procedure / adverse effects*
Glucocorticoids / therapeutic use
Humans
Hypoplastic Left Heart Syndrome / surgery*
Male
Piperazines / therapeutic use
Postoperative Complications / drug therapy
Postoperative Complications / etiology*
Postoperative Complications / physiopathology*
Purines / therapeutic use
Sildenafil Citrate
Sulfones / therapeutic use
Vasodilator Agents / therapeutic use

Substances

Glucocorticoids
Piperazines
Purines
Sulfones
Vasodilator Agents
Budesonide
Sildenafil Citrate